Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients "B-CAUSE"


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Time between last documented stroke (either haemorrhagic or ischemic) and study inclusion date equal or longer than 1 year
- Documented upper limb spasticity, with or without lower limb spasticity
- Naive to BoNT-A injections for spasticity treatment
- Provide written informed consent (signed by the patient or his legal representative) prior to any study-related procedure

Exclusion Criteria

- Previous surgical procedure for spasticity treatment, including neurotomy, rhizotomy and intrathecal pump implants
- Previous phenol injection and/or indication to receive phenol during the study duration
- Contraindications to any BoNT-A preparations
- Patient and/or caregiver unable to comply with the study requirements
- The patient has already been included in the study